https://doi.org/10.4081/mem.2001.741
Some Remarks Concerning the Embryos Bill of the Dutch Government
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
After many years of delay the actual Dutch government has presented a detailed bill regarding embryo experiments, which has recently been passed by Parliament, but still has to be discussed in the senate. While permitting research with rest embryos for medical-biological ends, it forbids, albeit for the time being, creating embryos solely for the purpose of research. The bill includes, however, the possibility to decide after three to five years by Royal Decree that embryos may also be created only for scientific research. A few articles which will then be effective are already written into the bill. It has thus been stipulated beforehand the embryos especially created for scientific purposes may only be used for research concerning infertility, artificial reproduction, congenital abnormalities and transplant medicine.
The government has proposed the permission of experiments with rest embryos and a temporary prohibitions of creating embryos solely for research taking into account four factors: respect for human life, the interest of medical science, the social acceptability of the creation for solely research in the Netherlands and that abroad. The original idea of possibly allowing after five to seven years the modification of the genetic material of the nucleus of germ cells has been abandoned in line with the 2001/20/EC European Directive regarding the mutual harmonisation of provisions concerning medical research.
Room is however left for the 'in vitro nuclear transplantation' (or better cytoplasm transplantation) for the treatment of mitochondrial disorders. After that the creation of embryos for other purposes than pregnancy will have been allowed, cloning will be permitted for transplant medicine, but not for the production of a series of genetically identical individuals. The fusion of human and animal gametes is only permitted if the resulting being will not reach multicellular stage. According to the bill it is permitted to create chimeras by combining human with other human or animal embryos with a view to investigating human embryonal development, provided that the resulting chimera will not be kept alive longer than two weeks. The bill is here discussed from the perspective of catholic morla doctrine and international conventions.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.